About
Aaron Sandoski is a managing director at Norwich Ventures and founding partner at Medtech Convergence Fund. His portfolio includes investments in Alpheus Medical, Brixton Biosciences, Lexington Medical, Nanopath, Perfuze, Podimetrics, and Vaxess Technologies, with prior exits including Affera (acquired by Medtronic), Arterys (acquired by Tempus), Intelligent Bio-systems (acquired by Qiagen), Pelvalon (acquired by Laborie), and Rhythmia Medical (acquired by Boston Scientific). He is co-author of How the Wise Decide.
Experience
- Medtech Convergence FundFounding Partnercurrent2020 — presentBoston, Massachusetts, United States
- Norwich VenturesCo-founder & Managing Directorcurrent2004 — presentWaltham, Massachusetts, United States
- NanopathInvestor/Board Membercurrent2022 — presentCambridge, Massachusetts, United States
- Lexington Medical, IncInvestor/Board Membercurrent2015 — presentBedford, Massachusetts, United States
- PodimetricsInvestor/Board Membercurrent2013 — presentSomerville, Massachusetts, United States
- MassMEDICBoard Membercurrent2015 — presentBoston, MA
- Affera, Inc.Investor/Board Member2014 — 2022Watertown, Massachusetts, United States
- Pelvalon (acquired by Laborie)Investor/Board Member2010 — 2021
- Vaxess TechnologiesInvestor/Board Member2013 — 2019Cambridge, Massachusetts, United States
- Daktari DiagnosticsInvestor/Board Member2009 — 2017Cambridge, Massachusetts, United States
- Rhythmia Medical, Inc.Investor/Board Member2007 — 2012Burlington, Massachusetts, United States
- Intelligent BIo-Systems, Inc.- A Qiagen CompanyInvestor/Board Member2009 — 2012Waltham, Massachusetts, United States
- DEKA Research & DevelopmentBusiness Development2001 — 2002Manchester, NH
- SolsparkDirector, Business Development2000New York, NY
- Express Scripts/YourPharmacyManager, Marketing1999 — 2000Greater St. Louis
- McKinsey & CompanyAssociate1996 — 1999New York, NY
Education
- Harvard Business SchoolMBA2002 — 2004
- Dartmouth CollegeBA, Chemistry and Economics1992 — 1996
Skills & more
+6 more
Angel InvestingDeal SourcingPrivate EquityStrategyMarket AnalysisEmerging MarketsLanguages English
From Aaron's professional profile.
Same school
Also attended Harvard Business School1,777
+ 1,771 more
Also attended Dartmouth College310
+ 304 more
Shared employers
Also worked at Podimetrics1
Also worked at MassMEDIC1
Also worked at Pelvalon (acquired by Laborie)1
Deals · 4
Lexington Medical, IncBoard seat
via Norwich Ventures · filed Apr 2025 · $37.8M raise
NanopathBoard seat
via Norwich Ventures · filed Feb 2025 · $6M raise
PodimetricsBoard seat
via Norwich Ventures · filed Apr 2022 · $60M raise
Daktari DiagnosticsBoard seat
via Norwich Ventures · filed May 2016 · $22.5M raise
Attribution from SEC filings, press coverage, and firm rosters.
